Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-877 DDI Study with Warfarin in Healthy Volunteers
NCT02719431Phase 1Completed
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pemafibrate in hyperlipidemia and dyslipidemia. Primary endpoint: International Normalized Ratio at 22 Days. Started Jan 2016; status: completed.
02
Drugs
pemafibrate
03
Conditions
hyperlipidemiadyslipidemia
Beyond the preview
Go deeper on NCT02719431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719431.